SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-009747
Filing Date
2024-03-07
Accepted
2024-03-07 18:40:03
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709854793.html 4  
1 FORM 4 wk-form4_1709854793.xml 4 3931
  Complete submission text file 0001628280-24-009747.txt   5663
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TOCAGEN INC. 4242 CAMPUS POINT COURT, STE. 500 SAN DIEGO CA 92121
Business Address
Kabbinavar Fairooz (Reporting) CIK: 0001774182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 24731839